COX5B and clear cell renal carcinoma: On the other hand, COX5B expression was decreased in breast cancer, colon cancer, clear cell renal cell carcinoma (RCC), pancreatic adenocarcinoma (PAAD), head and neck cancers, glioblastoma, and liver cancer (Fig. S1B).